✦ LIBER ✦

The metabolism of dopamine in the blood of ruminant animals: Formation of 3,4-dihydroxyphenylacetaldehyde

✍ Scribed by D.F. Sharman

Book ID: 113379428
Publisher: Elsevier Science
Year: 1987
Weight: 638 KB
Volume: 86
Category: Article
ISSN: 0306-4492
DOI: 10.1016/0742-8413(87)90158-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of the oxidative metabolism o

Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal

✍ V.R. Florang; J.N. Rees; N.K. Brogden; D.G. Anderson; T.D. Hurley; J.A. Doorn 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 360 KB

The metabolism of dopamine in the blood

The metabolism of dopamine in the blood of ruminant animals: An enzyme system to metabolize dopamine released from the mast cells in these species?

✍ Sharman, D.F.; Kelly, M.J.; Loňcar-Stevanović, H. 📂 Article 📅 1983 🏛 Elsevier Science ⚖ 697 KB

Metabolic stress in PC12 cells induces t

Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde

✍ I. Lamensdorf; G. Eisenhofer; J. Harvey-White; Y. Hayakawa; K. Kirk; I.J. Kopin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

3,4-Dihydroxyphenylacetaldehyde (DOPAL) has been reported to be a toxic metabolite formed by the oxidativedeamination of dopamine (DA) catalyzed by monoamine oxidase. This aldehyde is either oxidized to 3,4dihydroxyphenylacetic acid (DOPAC) by aldehyde dehydrogenase, an NAD-dependent enzyme or reduc

3,4-Dihydroxyphenylacetaldehyde potentia

3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells

✍ Itschak Lamensdorf; Graeme Eisenhofer; Judith Harvey-White; Amotz Nechustan; Ken 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 971 KB

Vesicular uptake blockade generates the

Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease

✍ Goldstein, David S.; Sullivan, Patti; Cooney, Adele; Jinsmaa, Yunden; Sullivan, 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

Quantitation of 3,4-Dihydroxyphenylaceta

Quantitation of 3,4-Dihydroxyphenylacetaldehyde and 3,4-Dihydroxyphenylglycolaldehyde, the Monoamine Oxidase Metabolites of Dopamine and Noradrenaline, in Human Tissues by Microcolumn High-Performance Liquid Chromatography

✍ William J. Burke; Hyung D. Chung; Shu Wen Li 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 56 KB

We recently described the chemical synthesis of 3, 4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde, the monamine oxidase metabolites of dopamine and noradrenaline, respectively. We demonstrated the neurotoxicity of these compounds. Catecholamine nerve cells which synthesize these